The United Kingdom Model for End-Stage Liver Disease (UKELD) predicts mortality in patients with end-stage liver disease for transplant planning.

The MELD and UKELD scores have statistical validation and use objective and widely available laboratory tests. However, both scores have important limitations.

The United Kingdom Model for End-Stage Liver Disease or UKELD is a medical scoring system used to predict the prognosis of patients with chronic liver disease.

MELD and UKELD are primarily intended to predict waiting list mortality and therefore urgency for transplant, but perform relatively poorly at predicting ...

The United Kingdom MELD (UKELD) score is derived from the patient's serum sodium, creatinine and bilirubin, and INR. It was developed by an analysis of 1103 ...

Conclusions: UKELD is better in predicting the waiting list mortality and post-LT mortality than MELD. Disclosure: All authors have declared no conflicts of ...

5 мая 2024 г. · UKELD, MELD, and MELD 3.0 did not differ by age (median UKELD scores of 56 for patients aged ≥60 years vs 56 for patients aged 25–49 years; MELD ...

Moreover, we have found that a MELD score of 10 or above prior to conception has an 83% sensitivity and specificity for predicting a serious liver-related ...

Maternal complications (ascites, enceph- alopathy, or variceal hemorrhage) occurred in 10% of patients and were associated with higher MELD (P ⫽ .01) and UKELD.

The Mann–Whitney U test was used to compare United Kingdom Model for End-Stage Liver Disease and Model for End Stage Liver Disease (UKELD and MELD, respectively) ...